Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Not a healthcare professional? Go to the patient or caregiver website.

AZULFIDINE® (sulfasalazine)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

AZULFIDINE® Quick Finder

INDICATIONS AND USAGE

AZULFIDINE Tablets are indicated:

in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and
for the...
Did you find an answer to your question? Yes No

DOSAGE AND ADMINISTRATION

The dosage of AZULFIDINE Tablets should be adjusted to each individual's response and tolerance.

Initial Therapy

Adults...

Did you find an answer to your question? Yes No

CONTRAINDICATIONS

AZULFIDINE Tablets are contraindicated in:

 
Patients with intestinal or urinary obstruction,
 
Patients with porphyria as sulfonamides have been reported to precipitate...
Did you find an answer to your question? Yes No

WARNINGS

Hepatic, Renal, and Hematologic Toxicity or Other Conditions

Only after critical appraisal should AZULFIDINE Tablets be given to...

Did you find an answer to your question? Yes No

ADVERSE REACTIONS

The most common adverse reactions associated with sulfasalazine are anorexia, headache, nausea, vomiting, gastric distress, and apparently reversible oligospermia. These occur in about one-third of the...

Did you find an answer to your question? Yes No

DRUG ABUSE AND DEPENDENCE

None reported.

Did you find an answer to your question? Yes No

OVERDOSAGE

There is evidence that the incidence and severity of toxicity following overdosage are directly related to the total serum sulfapyridine concentration. Symptoms of overdosage may include nausea, vomiting, gastric...

Did you find an answer to your question? Yes No

DESCRIPTION

AZULFIDINE Tablets contain sulfasalazine, 500 mg, for oral administration.

Therapeutic Classification: Anti-inflammatory agent.

Chemical Designation...

Did you find an answer to your question? Yes No

CLINICAL PHARMACOLOGY

Pharmacodynamics

The mode of action of sulfasalazine (SSZ) or its metabolites, 5-aminosalicylic acid (5-ASA) and sulfapyridine (SP), may be...

Did you find an answer to your question? Yes No

REFERENCES

1.
Mogadam M, et al. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 1981;80:72–6.
2.
Kaufman DW, editor. Birth defects and...
Did you find an answer to your question? Yes No

HOW SUPPLIED

AZULFIDINE Tablets, 500 mg, are round, gold-colored, scored tablets, monogrammed "101" on one side and "KPh" on the other. They are available in the following package sizes:

...
Did you find an answer to your question? Yes No

This product's label may have been updated. For current full prescribing information, please visit www.pfizer.com.

...
Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event